Altimmune, Inc. (ALT)
NASDAQ · Healthcare
Altimmune, Inc. Net Income 2010–2025
Altimmune, Inc. annual/quarterly net income history and growth rate from 2010 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Altimmune, Inc. net income for the quarter ending September 30, 2025 was -19.0 M, a 16.77% decrease year-over-year.
- Altimmune, Inc. net income for the twelve months ending September 30, 2025 was -83.6 M, a 2.55% decrease year-over-year.
- Altimmune, Inc. annual net income for 2025 was -88.1 M, a 7.33% decrease from 2024.
- Altimmune, Inc. annual net income for 2024 was -95.1 M, a 7.48% increase from 2023.
- Altimmune, Inc. annual net income for 2023 was -88.4 M, a 4.41% increase from 2022.
- Altimmune, Inc. annual net income for 2022 was -84.7 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Altimmune, Inc. Net Income — FAQ
Altimmune, Inc. (ALT) net income over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
What is Altimmune, Inc.'s net income?
Altimmune, Inc. (ALT) reported net income of -$88M for fiscal 2025.
Where can I see ALT's net income history?
The chart and table above show Altimmune, Inc.'s net income by year and by quarter, including the growth rate.